Niagen Bioscience (NAGE) Goodwill & Intangibles (2011 - 2026)
Niagen Bioscience's (NAGE) quarterly Goodwill & Intangibles came in at $5.5 million in Q1 2026, up 1603.42% year-on-year from $322000.0 in Q1 2025, and down 3.09% on a QoQ basis from $5.7 million in Q4 2025.
Niagen Bioscience (NAGE) Goodwill & Intangibles (2011 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 15 years of Goodwill & Intangibles data on file, last reported at $5.5 million in Q1 2026.
- On a quarterly basis, Goodwill & Intangibles rose 1603.42% year-over-year to $5.5 million in Q1 2026; TTM through Mar 2026 was $5.5 million, a 1603.42% increase from a year earlier, with the FY2025 full-year figure at $5.7 million, up 1476.6% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $5.5 million, down from $5.7 million in the prior quarter.
- Over the last five years, Goodwill & Intangibles for NAGE reached as high as $5.7 million in Q4 2025 and fell as low as $246000.0 in Q3 2025.
- Historically, Goodwill & Intangibles has averaged $1.1 million across 5 years, with a median of $552000.0 in 2023.
- Across the five-year window, Goodwill & Intangibles tumbled 38.04% in 2025 and soared 1603.42% in 2026, its largest moves.
- Year by year, Goodwill & Intangibles stood at $671000.0 in 2022, then fell by 23.99% to $510000.0 in 2023, then declined by 29.61% to $359000.0 in 2024, then soared by 1476.6% to $5.7 million in 2025, then fell by 3.09% to $5.5 million in 2026.
- Per Business Quant data, the three most recent Goodwill & Intangibles figures were $5.5 million in Q1 2026, $5.7 million in Q4 2025, and $246000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 473.74 Bn | 468.95 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.07 Bn | 114.82 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.00 Bn | 61.24 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Niagen Bioscience | 260.13 Mn | 193.58 Mn | 19.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.49 Mn |
| Dec 31, 2025 | 5.66 Mn |
| Sep 30, 2025 | 246,000.00 |
| Jun 30, 2025 | 284,000.00 |
| Mar 31, 2025 | 322,000.00 |
| Dec 31, 2024 | 359,000.00 |
| Sep 30, 2024 | 397,000.00 |
| Jun 30, 2024 | 435,000.00 |
| Mar 31, 2024 | 472,000.00 |
| Dec 31, 2023 | 510,000.00 |
| Sep 30, 2023 | 552,000.00 |
| Jun 30, 2023 | 591,000.00 |
| Mar 31, 2023 | 630,000.00 |
| Dec 31, 2022 | 671,000.00 |
| Sep 30, 2022 | 714,000.00 |
| Jun 30, 2022 | 758,000.00 |
| Mar 31, 2022 | 808,000.00 |
| Dec 31, 2021 | 857,000.00 |
| Sep 30, 2021 | 908,000.00 |
| Jun 30, 2021 | 961,000.00 |